A snowstorm in a gin bottle? M&S IP strategy outmanoeuvres Aldi
As many will already be aware, M&S and Aldi recently called a truce in the viral dispute involving the M&S...
The current state of the EV industry
After a rocky start with several silicon valley busts, it is safe to say that Electric Vehicles (EVs) are here...
From text generation to patent prosecution: could ChatGPT be the next legal tech breakthrough?
The use of Artificial Intelligence (AI) within Intellectual Property (IP) is an issue that continues to make headlines. The most...
Cooking up an innovative storm? Patent opportunities in food and beverages
The food and drink industry is constantly evolving, with new trends emerging every year. From plant-based meats and dairy alternatives,...
Hydrogen patents increase as our clean energy future begins to brighten: EPO and IEA report details the encouraging advancements in hydrogen energy innovation across countries and industry sectors
The worldwide search for clean energy solutions has never been so important. We are confined by our dependence on fossil...
When innovation becomes mainstream: the rise of branded EV batteries
With the scope of patentability narrowing by the day, the Intellectual Property (IP) protection companies afford their batteries will soon...
Unified Patent Court and Unitary Patent go live on 1 June 2023
Germany has today ratified the UPC Agreement meaning the go-live date for the Unitary Patent (UP) and the Unified Patent Court...
Safeguarding creativity: the fundamental principles of IP
Intellectual Property (IP) always seems to pique media attention. In 2022, brands such as Red Bull and Zara hit the headlines...
UK IPO announces address for service changes with immediate effect
Background The UK IPO’s approach in handling communications arising out of third-party actions filed against UK trade mark and design...
Get ready for the Unitary Patent and Unified Patent Court to go live: 1 June 2023
The current go-live date for the Unitary Patent (UP) and the Unified Patent Court (UPC) is 1 June 2023. For...
When M&A goes bad: overlook IP due diligence at your peril
According to a Harvard Business Review article, “Deal making is glamorous; due diligence is not”. Do you think this is...
Lecanemab: could the drug with modest benefits make a big difference to Alzheimer’s patients?
Currently more than 55 million people live with dementia worldwide, with the number of people living with the disease expected to triple...